Ketamine Side Effects, Safety and Risks in Nevada

Ketamine-class treatments can help some people with depression. They are also powerful dissociative anaesthetics with a real side-effect profile, a controlled-substance schedule, and monitoring rules that exist for a reason. This page is the plain version of those risks.

Common short-term effects

In treatment-resistant depression studies the most common side effects of Spravato were dissociation, dizziness, nausea, sedation, vertigo, reduced sense of touch, anxiety, lethargy, increased blood pressure, vomiting, feeling drunk, and headache. as of 30 Apr 2025 · U.S. Food and Drug Administration (source 1, opens in a new tab)The label lists a different set for the major-depressive-disorder-with-acute-suicidality indication. The two lists should not be conflated.

Spravato carries a boxed warning for sedation, dissociation, respiratory depression, abuse and misuse, and suicidal thoughts and behaviours — the same class of risks that justify the REMS clinic-only distribution system. as of 30 Apr 2025 · U.S. Food and Drug Administration (source 1, opens in a new tab)

During a session, blood pressure often rises for a while and then settles. Clinics check it for that reason. Nausea is common enough that many sites offer anti-nausea medicine. Tell staff early if you feel panicked, over-sedated, or like the room is too much — the dose rate can often be adjusted.

Dissociation — what people usually mean

Dissociation is a sense of detachment from your body, thoughts or surroundings. It can feel dreamlike, floaty, or frankly unpleasant. It is expected with these medicines at psychiatric doses, it is temporary for most people, and it is one of the reasons Spravato may only be given under observation.

A healthcare provider must monitor the patient for at least two hours after every Spravato dose before deciding they are ready to leave. as of 30 Apr 2025 · U.S. Food and Drug Administration (source 2, opens in a new tab)

Bladder and urinary effects

Long-term, high-frequency recreational ketamine use is associated with ketamine-induced ulcerative cystitis — painful bladder, frequency, urgency and, in severe cases, irreversible damage — and while psychiatric clinic doses are far lower, urinary symptoms should be reported early rather than ignored. as of 1 Jan 2023 · StatPearls / NCBI Bookshelf (source 1, opens in a new tab)Most cystitis case series describe chronic recreational exposure, not a standard six-infusion clinic course. Absence of a published clinic-dose incidence figure is not proof of zero risk.

If you develop new urinary pain, blood in the urine, or a sudden need to void constantly during a course of treatment, stop and call the clinic rather than waiting for the next booster. Clinics that never mention this risk are not doing you a favour.

Dependence, tolerance and withdrawal

Ketamine is a Schedule III controlled substance with accepted medical use and a recognised potential for psychological dependence, tolerance with repeated high-dose exposure, and a withdrawal picture that can include craving, sleep disturbance and mood changes after heavy non-medical use. as of 18 Jul 2026 · U.S. Drug Enforcement Administration (source 2, opens in a new tab)Schedule status describes abuse potential relative to other controlled drugs; it is not a prediction that a monitored clinic course will produce dependence.

Ketamine and its mirror-image form esketamine are Schedule III controlled substances under federal law, which means they have accepted medical uses but can be misused. as of 18 Jul 2026 · U.S. Drug Enforcement Administration (source 3, opens in a new tab)Esketamine has no separate DEA listing; it is covered as an enantiomer of ketamine, and the Spravato label carries the CIII designation.

A monitored clinic course is not the same exposure pattern as daily recreational use. Still, ask any programme that pushes frequent at-home dosing without review how they watch for escalating use — and walk away if they cannot answer.

Half-life and how long effects last

After intravenous dosing, ketamine's elimination half-life in adults is typically about two to three hours, with psychoactive effects that peak during the infusion and usually settle over the following hours — which is why clinics plan observation time and why next-day driving rules still apply after esketamine. as of 1 Jan 2022 · U.S. Food and Drug Administration (source 3, opens in a new tab)

After a Spravato dose you must not drive or operate machinery until the next day, following a restful night's sleep, so you need to arrange a ride home from every session. as of 30 Apr 2025 · U.S. Food and Drug Administration (source 6, opens in a new tab)

Feeling “mostly fine” an hour after a session is not permission to drive. The formal rule for Spravato is next-day driving only after restful sleep; many IV clinics apply the same caution.

Ketamine on a drug test

Standard workplace urine drug screens do not routinely include ketamine; detection usually requires a specific assay, and published detection windows after use are often on the order of a few days in urine depending on dose, frequency, metabolism and the laboratory method. as of 18 Jul 2026 · StatPearls / NCBI Bookshelf (source 3, opens in a new tab)Employers, courts and sports bodies may order expanded panels. If a drug test is pending, disclose prescribed treatment to the medical review officer rather than relying on a generalisation.

At-home and microdosing risk

At-home and microdosing ketamine programmes remove the on-site monitoring that clinic protocols use to catch blood-pressure spikes, severe dissociation, sedation and diversion — so the convenience trade-off is a real safety gap, not a minor difference in setting. as of 30 Apr 2025 · U.S. Food and Drug Administration (source 1, opens in a new tab)Spravato cannot be taken at home under the REMS. Compounded at-home racemic products are a different regulatory pathway and are not REMS-certified substitutes.

Nevada does not require an in-person examination before prescribing controlled substances by telehealth. State law allows the patient relationship to be established by telehealth where that is clinically appropriate, and treats the relationship as valid if you were examined in person or by telehealth within the previous six months. The clinician must hold a Nevada licence. as of 18 Jul 2026 · Nevada Legislature (source 7, opens in a new tab)Federal DEA telemedicine flexibilities run separately and expire at the end of 2026, and they require video — audio-only does not qualify for ketamine. Spravato cannot be prescribed for home use in any case.

Microdosing content online often treats ketamine like a productivity supplement. That framing erases respiratory depression, blood-pressure spikes, dependence risk and diversion. If a seller will not discuss monitoring, that is the answer.

Nevada Prescription Monitoring Program (NV PMP) in Nevada

Prescription monitoring is three different questions — what must be reported, when a prescriber must check, and how that applies to ketamine — not one slogan.

What must be reported

Nevada's Prescription Monitoring Program is run by the State Board of Pharmacy. Every registered dispenser must upload details of any Schedule II, III, IV or V controlled substance dispensed for human use, no later than the end of the next business day. as of 18 Jul 2026 · Nevada Legislature (source 7, opens in a new tab)Many summaries say Schedules II to IV. The current statute says II to V.

When a prescriber must check

Nevada requires a practitioner to obtain and review a patient utilisation report before issuing an initial prescription for any Schedule II, III or IV controlled substance — and for a Schedule V opioid — then at least once every ninety days for as long as that treatment continues. The only exception covers cancer, sickle cell disease and hospice or palliative care, and only where getting the report would unreasonably delay care. as of 18 Jul 2026 · Nevada Legislature (source 7, opens in a new tab)

Does this apply to ketamine?

Partly, and Nevada is stricter here than several neighbouring states. Ketamine is Schedule III in Nevada, and Schedule III sits squarely inside the state's check requirement — so if a clinician writes you a ketamine prescription to take away, they must run the report first and again every ninety days. Whether the requirement reaches an infusion given entirely inside a clinic is unsettled, because the duty is written around issuing a prescription rather than administering a dose. as of 18 Jul 2026 · Nevada Legislature (source 7, opens in a new tab)No Nevada board guidance or court decision resolves the in-clinic administration question, so we do not present either answer as settled.

When to seek urgent help

• Chest pain, severe headache, or neurological symptoms after a session
• Breathing that feels dangerously slow or shallow
• Suicidal thoughts that intensify, or any plan or intent to act on them
• Manic activation: drastically reduced need for sleep, racing speech, reckless behaviour
• Severe allergic reaction

If someone is in immediate danger, call 911. For a mental-health crisis, call or text 988, or text HOME to 741741.

If you are in crisis, call or text 988 to reach the 988 Suicide & Crisis Lifeline, or text HOME to 741741 to reach the Crisis Text Line. Both are free and available 24 hours a day. as of 18 Jul 2026 · 988 Suicide and Crisis Lifeline (source 1, opens in a new tab)

Related pages

• What a session involves
• Legal status and who may prescribe in Nevada
• Bipolar-specific risks
• Who is typically assessed for treatment

Frequently asked questions